Read More Pharma Industry News Pollon Life files for Hong Kong IPO: Is Jack Ma’s stem cell bet about to pay off? Find out how Pollon Life, backed by Jack Ma’s Yunfeng Capital, is planning a Hong Kong IPO and what it signals for China’s biotech revival. bySrinathOctober 29, 2025